in establishing a combined and companion QMS is to understand the regulatory frameworks that govern medical devices and combination products. In the United States, the FDA regulates these products under 21 CFR Part 820, which outlines the Quality System Regulation (QSR). In the EU, the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) set the standards for compliance, while ISO 13485 provides a globally recognized framework for quality management systems.

Objectives: The primary objective of this step is to familiarize yourself with the relevant regulations and standards that will inform your QMS development. Understanding these requirements is crucial for ensuring that your QMS is compliant and effective.

Documentation: Key documents to review include:

• 21 CFR Part 820 – Quality System Regulation
• ISO 13485:2016 – Medical Devices Quality Management Systems
• EU MDR and IVDR guidelines

Roles: Quality managers and regulatory affairs professionals should lead this phase, collaborating with cross-functional teams to gather insights and ensure comprehensive understanding.

Inspection Expectations: During inspections, regulatory bodies will expect evidence of your understanding of applicable regulations, including documented training and assessments of compliance with these standards.

Step 2: Defining the Scope of Your QMS

Once you have a solid understanding of the regulatory landscape, the next step is to define the scope of your QMS. This involves identifying the specific processes, products, and services that will be included in your QMS framework.

Objectives: The objective here is to create a clear and concise scope statement that outlines what your QMS will cover, ensuring alignment with regulatory requirements and organizational goals.

Documentation: The scope statement should include:

• Product categories (e.g., medical devices, combination products)
• Geographical markets (e.g., US, EU, UK)
• Applicable regulatory requirements

Roles: Quality managers should lead this effort, with input from product development, regulatory affairs, and operations teams to ensure all relevant aspects are considered.

Inspection Expectations: Inspectors will review the scope of your QMS to ensure it adequately covers all relevant processes and complies with applicable regulations.

Step 3: Developing QMS Processes and Procedures

The development of processes and procedures is a critical step in establishing a combined and companion QMS. This phase involves creating detailed documentation that outlines how your organization will meet regulatory requirements and ensure product quality.

Objectives: The goal is to develop a comprehensive set of procedures that address all aspects of your QMS, including design control, risk management, document control, and corrective and preventive actions (CAPA).

Documentation: Essential documents include:

• Standard Operating Procedures (SOPs)
• Work instructions
• Quality manuals

Roles: Quality managers should oversee the development of these documents, with contributions from subject matter experts across various departments.

Inspection Expectations: During inspections, regulatory bodies will expect to see well-documented procedures that are followed consistently. Inspectors will look for evidence of adherence to these procedures in practice.

Step 4: Implementing the QMS

With processes and procedures developed, the next step is to implement the QMS across your organization. This phase involves training staff, integrating QMS processes into daily operations, and ensuring that everyone understands their roles and responsibilities.

Objectives: The objective is to ensure that the QMS is fully operational and that all employees are trained and competent in their roles within the system.

Documentation: Key documents for this phase include:

• Training records
• Implementation plans
• Communication materials

Roles: Quality managers should lead the implementation effort, supported by department heads who will facilitate training and integration of QMS processes.

Inspection Expectations: Inspectors will assess the effectiveness of your QMS implementation, looking for evidence of employee training and engagement with the QMS processes.

Step 5: Monitoring and Measuring QMS Performance

After implementation, it is essential to monitor and measure the performance of your QMS. This step involves establishing metrics and key performance indicators (KPIs) to evaluate the effectiveness of your quality management processes.

Objectives: The goal is to identify areas for improvement and ensure that the QMS is achieving its intended outcomes.

Documentation: Important documents include:

• Performance metrics and KPIs
• Internal audit reports
• Management review meeting minutes

Roles: Quality managers should lead the monitoring efforts, with input from cross-functional teams to ensure comprehensive evaluation of QMS performance.

Inspection Expectations: Inspectors will expect to see evidence of monitoring activities, including documented performance metrics and actions taken in response to identified issues.

Step 6: Continuous Improvement of the QMS

The final step in establishing a combined and companion QMS is to implement a continuous improvement process. This involves regularly reviewing and updating your QMS to adapt to changing regulatory requirements, technological advancements, and organizational needs.

Objectives: The objective is to create a culture of continuous improvement that fosters innovation and enhances product quality.

Documentation: Key documents for this phase include:

• Change control records
• Improvement plans
• Feedback and suggestions from employees

Roles: Quality managers should spearhead continuous improvement initiatives, encouraging input from all employees to foster a culture of quality.

Inspection Expectations: Inspectors will look for evidence of continuous improvement efforts, including documented changes made to the QMS and the rationale behind those changes.

Conclusion

Implementing a combined and companion QMS for medical devices and combination products is a complex but essential process for ensuring compliance with regulatory standards such as 21 CFR, EU GMP, and ISO certification. By following these steps—understanding the regulatory landscape, defining the scope of your QMS, developing processes and procedures, implementing the QMS, monitoring performance, and fostering continuous improvement—organizations can create a robust quality management system that not only meets regulatory requirements but also enhances product quality and patient safety.

For further guidance on regulatory compliance, refer to the FDA and EMA resources, which provide valuable insights into maintaining compliance in the ever-evolving landscape of medical devices and combination products.